Literature DB >> 19776749

Cardiovascular disease risk, vascular health and erectile dysfunction among middle-aged, clinically depressed men.

B M Hoffman1, A Sherwood, P J Smith, M A Babyak, P M Doraiswamy, A Hinderliter, J A Blumenthal.   

Abstract

Erectile dysfunction (ED) is especially common in men with major depressive disorder (MDD). This study examined the extent to which risk factors for cardiovascular disease (CVD) and vascular endothelial dysfunction were associated with ED severity in MDD patients. The sample included 46 middle-aged [M (s.d.)=53 (7) years], sedentary men diagnosed with MDD. ED severity was assessed by the Arizona Sexual Experiences Scale (ASEX), item 3. Depression severity was measured by the Beck Depression Inventory-II (BDI). The Framingham risk score was calculated as a composite measure of CVD risk factors. Vascular endothelial function was measured by flow-mediated dilation (FMD) of the brachial artery. Regression analysis showed that ASEX scores were predicted by the greater Framingham risk score (beta=0.41, P=0.008) and lower FMD (beta=-0.38, P=0.01), but not by BDI scores (beta=0.00, P=0.99). When FMD was included in the regression model, the relationship between Framingham risk and ASEX scores was partially attenuated (beta=0.27, P=0.08). ED was associated with greater CVD risk and impaired vascular endothelial function in depressed men. CVD risk factors may affect ED through impairment of vascular endothelial function.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19776749      PMCID: PMC3635136          DOI: 10.1038/ijir.2009.43

Source DB:  PubMed          Journal:  Int J Impot Res        ISSN: 0955-9930            Impact factor:   2.896


  29 in total

1.  The Arizona Sexual Experience Scale (ASEX): reliability and validity.

Authors:  C A McGahuey; A J Gelenberg; C A Laukes; F A Moreno; P L Delgado; K M McKnight; R Manber
Journal:  J Sex Marital Ther       Date:  2000 Jan-Mar

Review 2.  Erectile dysfunction.

Authors:  T F Lue
Journal:  N Engl J Med       Date:  2000-06-15       Impact factor: 91.245

Review 3.  The cardiovascular disease continuum validated: clinical evidence of improved patient outcomes: part I: Pathophysiology and clinical trial evidence (risk factors through stable coronary artery disease).

Authors:  Victor J Dzau; Elliott M Antman; Henry R Black; David L Hayes; JoAnn E Manson; Jorge Plutzky; Jeffrey J Popma; William Stevenson
Journal:  Circulation       Date:  2006-12-19       Impact factor: 29.690

4.  The prevalence of erectile dysfunction in the primary care setting: importance of risk factors for diabetes and vascular disease.

Authors:  Steven A Grover; Ilka Lowensteyn; Mohammed Kaouache; Sylvie Marchand; Louis Coupal; Emidio DeCarolis; Joseph Zoccoli; Isabelle Defoy
Journal:  Arch Intern Med       Date:  2006-01-23

5.  Erectile dysfunction and subsequent cardiovascular disease.

Authors:  Ian M Thompson; Catherine M Tangen; Phyllis J Goodman; Jeffrey L Probstfield; Carol M Moinpour; Charles A Coltman
Journal:  JAMA       Date:  2005-12-21       Impact factor: 56.272

6.  Incidence of erectile dysfunction in men 40 to 69 years old: longitudinal results from the Massachusetts male aging study.

Authors:  C B Johannes; A B Araujo; H A Feldman; C A Derby; K P Kleinman; J B McKinlay
Journal:  J Urol       Date:  2000-02       Impact factor: 7.450

7.  Correlation between flow-mediated dilation and erectile dysfunction.

Authors:  Imre Kovács; Albert Császár; Janos Toth; György Siller; Attila Farkas; Jeno Tarján; Judit Horváth; Akos Koller
Journal:  J Cardiovasc Pharmacol       Date:  2008-02       Impact factor: 3.105

8.  General cardiovascular risk profile for use in primary care: the Framingham Heart Study.

Authors:  Ralph B D'Agostino; Ramachandran S Vasan; Michael J Pencina; Philip A Wolf; Mark Cobain; Joseph M Massaro; William B Kannel
Journal:  Circulation       Date:  2008-01-22       Impact factor: 29.690

9.  Erectile dysfunction prospectively associated with cardiovascular disease in the Dutch general population: results from the Krimpen Study.

Authors:  B W V Schouten; A M Bohnen; J L H R Bosch; R M D Bernsen; J W Deckers; G R Dohle; S Thomas
Journal:  Int J Impot Res       Date:  2007-08-30       Impact factor: 2.896

10.  Exercise and pharmacotherapy in the treatment of major depressive disorder.

Authors:  James A Blumenthal; Michael A Babyak; P Murali Doraiswamy; Lana Watkins; Benson M Hoffman; Krista A Barbour; Steve Herman; W Edward Craighead; Alisha L Brosse; Robert Waugh; Alan Hinderliter; Andrew Sherwood
Journal:  Psychosom Med       Date:  2007-09-10       Impact factor: 4.312

View more
  2 in total

Review 1.  Sexual dysfunction and cardiovascular diseases: a systematic review of prevalence.

Authors:  Elisabete Rodrigues Nascimento; Ana Claudia Ornelas Maia; Valeska Pereira; Gastão Soares-Filho; Antonio Egidio Nardi; Adriana Cardoso Silva
Journal:  Clinics (Sao Paulo)       Date:  2013-11       Impact factor: 2.365

Review 2.  Cardiovascular risk assessment in patients with a severe mental illness: a systematic review and meta-analysis.

Authors:  Quintí Foguet-Boreu; Maria Isabel Fernandez San Martin; Gemma Flores Mateo; Edurne Zabaleta Del Olmo; Luís Ayerbe García-Morzon; Maria Perez-Piñar López; Luis Miguel Martin-López; Javier Montes Hidalgo; Concepción Violán
Journal:  BMC Psychiatry       Date:  2016-05-12       Impact factor: 3.630

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.